File Download

There are no files associated with this item.

Conference Paper: Pembrolizumab (MK-3475) vs Standard of Care Chemotherapy in Platinum Pretreated, Recurrent or Metastatic Nasopharyngeal Cancer: the Phase 2 Keynote-122 Study

TitlePembrolizumab (MK-3475) vs Standard of Care Chemotherapy in Platinum Pretreated, Recurrent or Metastatic Nasopharyngeal Cancer: the Phase 2 Keynote-122 Study
Authors
Issue Date2016
Citation
The American Head and Neck Society (AHNS) 9th International Conference of Head and Neck Cancer, Seattle, WA., 16-20 July 2016. How to Cite?
DescriptionConference Theme: Technology Transforming Head and Neck Cancer Care
Poster no. P343
Persistent Identifierhttp://hdl.handle.net/10722/241014

 

DC FieldValueLanguage
dc.contributor.authorSiu, LL-
dc.contributor.authorLee, VHF-
dc.contributor.authorNgan, R-
dc.contributor.authorTo, KF-
dc.contributor.authorAhn, MJ-
dc.contributor.authorNg, QS-
dc.contributor.authorHong, RL-
dc.contributor.authorLin, JC-
dc.contributor.authorSwaby, RF-
dc.contributor.authorOwtscharuk-Sheldon, T-
dc.contributor.authorSaraf, S-
dc.contributor.authorChan, AT-
dc.date.accessioned2017-05-22T09:21:07Z-
dc.date.available2017-05-22T09:21:07Z-
dc.date.issued2016-
dc.identifier.citationThe American Head and Neck Society (AHNS) 9th International Conference of Head and Neck Cancer, Seattle, WA., 16-20 July 2016.-
dc.identifier.urihttp://hdl.handle.net/10722/241014-
dc.descriptionConference Theme: Technology Transforming Head and Neck Cancer Care-
dc.descriptionPoster no. P343-
dc.languageeng-
dc.relation.ispartofAHNS 9th International Conference of Head and Neck Cancer-
dc.titlePembrolizumab (MK-3475) vs Standard of Care Chemotherapy in Platinum Pretreated, Recurrent or Metastatic Nasopharyngeal Cancer: the Phase 2 Keynote-122 Study-
dc.typeConference_Paper-
dc.identifier.emailLee, VHF: vhflee@hku.hk-
dc.identifier.authorityLee, VHF=rp00264-
dc.identifier.hkuros272228-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats